{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-075603","form_type":"8-K","ticker":"CLSDQ","cik":"0001539029","company_name":"Clearside Biomedical, Inc.","filed_at":"2024-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.899030+00:00","generated_at":"2026-06-01T03:22:36.210336+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Clearside Biomedical stockholders elect all three director nominees, approve say-on-pay, ratify E&Y","bullets":["Directors Croarkin, Humphries, and Hutson elected with ~30M votes for each; no nominee withheld.","Advisory vote on executive compensation approved: 22.8M for, 5.2M against, 6.6M abstentions.","Ratification of Ernst & Young as independent auditor for FY2024 passed: 45.1M for, 4.9M against.","Total shares present at meeting: 50.1M (67% of 74.7M outstanding)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-075603","json":"https://secwatch.observer/filing/0000950170-24-075603.json","markdown":"https://secwatch.observer/filing/0000950170-24-075603.md","text":"https://secwatch.observer/filing/0000950170-24-075603.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1539029/000095017024075603/0000950170-24-075603-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1539029/000095017024075603/clsd-20240620.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:22:36.210336+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}